Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACYW135 meningococcal conjugate vaccine in 3–35 month-old children
CTR20182031Phase 2Completed
- Sponsor
- Beijing Luzhu Biotechnology
- Start
- Dec 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal (group A, C, Y, W135) polysaccharide conjugate vaccine in meningococcal disease, sponsored by Beijing Luzhu Biotechnology. Started Dec 2018; status: completed.
02
Drugs
meningococcal (group A, C, Y, W135) polysaccharide conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on CTR20182031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182031.